Literature DB >> 9701002

Review article: Relationship between Helicobacter pylori, atrophic gastritis and gastric cancer.

E J Kuipers1.   

Abstract

Helicobacter pylori causes chronic active inflammation of the gastric mucosa in the majority of infected patients. In a considerable number of them, this will eventually lead to a loss of gastric glands, and thus the establishment of atrophic gastritis. This is associated with the development of intestinal metaplasia and dysplasia. These consecutive conditions increase the risk for gastric cancer. particularly of the intestinal type. We reviewed the evidence that H. pylori plays an important role in this sequence of events that can lead to gastric cancer. This paper focuses on the difficulties in staging atrophic gastritis, the incidence and prevalence of this condition and the relation with H. pylori infection. Furthermore, it describes the evidence for the role of this organism and gastric mucosal atrophy in the aetiology of gastric cancer and focuses on the life-time incidence of gastric cancer in the presence of this bacterium.

Entities:  

Mesh:

Year:  1998        PMID: 9701002     DOI: 10.1111/j.1365-2036.1998.00009.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  26 in total

1.  Supra-angular biopsy is more reliable for atrophy recognization: analysis of 1598 cases for gastric mucosal histological examination.

Authors:  Ya-Li Zhang; Zhuo-Sheng Lai; Dian-Yuan Zhou; Nobutaka Yamada; Min Wen
Journal:  World J Gastroenterol       Date:  2000-12       Impact factor: 5.742

2.  Operative link for gastritis assessment vs operative link on intestinal metaplasia assessment.

Authors:  Massimo Rugge; Matteo Fassan; Marco Pizzi; Fabio Farinati; Giacomo Carlo Sturniolo; Mario Plebani; David Y Graham
Journal:  World J Gastroenterol       Date:  2011-11-07       Impact factor: 5.742

3.  Nickel-responsive induction of urease expression in Helicobacter pylori is mediated at the transcriptional level.

Authors:  A H van Vliet; E J Kuipers; B Waidner; B J Davies; N de Vries; C W Penn; C M Vandenbroucke-Grauls; M Kist; S Bereswill; J G Kusters
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

4.  Mucosal lymphocyte subsets and HLA-DR antigen expression in paediatric Helicobacter pylori-associated gastritis.

Authors:  A I Lopes; R M M Victorino; A M Palha; J Ruivo; A Fernandes
Journal:  Clin Exp Immunol       Date:  2006-07       Impact factor: 4.330

5.  Differences in oxidative stress dependence between gastric adenocarcinoma subtypes.

Authors:  Brigitte Bancel; Jacques Esteve; Jean-Christophe Souquet; Shinya Toyokuni; Hiroshi Ohshima; Brigitte Pignatelli
Journal:  World J Gastroenterol       Date:  2006-02-21       Impact factor: 5.742

6.  The ethanol extract isolated from Weiqi Decoction induces G₂/M arrest and apoptosis in AGS cells.

Authors:  Hai-lian Shi; Bao Tan; Guang Ji; Lan Lu; Jian-qun Xie
Journal:  Chin J Integr Med       Date:  2013-08-13       Impact factor: 1.978

7.  Biomarkers in various types of atrophic gastritis and their diagnostic usefulness.

Authors:  Kazimierz Rembiasz; Peter C Konturek; Danuta Karcz; Stanislaw J Konturek; Władysław Ochmanski; Wladyslaw Bielanski; Andrzej Budzynski; Jerzy Stachura
Journal:  Dig Dis Sci       Date:  2005-03       Impact factor: 3.199

8.  Houston Consensus Conference on Testing for Helicobacter pylori Infection in the United States.

Authors:  Hashem B El-Serag; John Y Kao; Fasiha Kanwal; Mark Gilger; Frank LoVecchio; Steven F Moss; Sheila E Crowe; Adam Elfant; Thomas Haas; Ronald J Hapke; David Y Graham
Journal:  Clin Gastroenterol Hepatol       Date:  2018-03-17       Impact factor: 11.382

Review 9.  Does gastric atrophy exist in children?

Authors:  Georges Dimitrov; Frederic Gottrand
Journal:  World J Gastroenterol       Date:  2006-10-21       Impact factor: 5.742

Review 10.  Helicobacter pylori: present status and future prospects in Japan.

Authors:  Hidekazu Suzuki; Toshifumi Hibi; Barry James Marshall
Journal:  J Gastroenterol       Date:  2007-02-16       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.